FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Remo Panaccione

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Living Beings

Young Adult

Geographic Areas

Canada

Co-author Network

Publications

TOP 3
Marietta Iacucci; Remo Panaccione; Subrata Ghosh
Advances in novel diagnostic endoscopic imaging techniques in inflammatory bowel disease.
Rachel Marion-Letellier; Remo Panaccione; Guillaume Savoye; Paul L Beck; Subrata Ghosh
Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches.
Marie-France Dubeau; Subrata Ghosh; Marietta Iacucci; Gilaad G Kaplan; Gordon W Moran; Paul L Beck; Remo Panaccione
Drug-induced inflammatory bowel disease and IBD-like conditions.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Remo Panaccione (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Marietta Iacucci; Remo Panaccione; Subrata Ghosh
Advances in novel diagnostic endoscopic imaging techniques in inflammatory bowel disease.
Inflammatory bowel diseases 2013;19(4):873-80.
2013: Rachel Marion-Letellier; Remo Panaccione; Guillaume Savoye; Paul L Beck; Subrata Ghosh
Polyunsaturated fatty acids in inflammatory bowel diseases: a reappraisal of effects and therapeutic approaches.
Inflammatory bowel diseases 2013;19(3):650-61.
2013: Marie-France Dubeau; Subrata Ghosh; Marietta Iacucci; Gilaad G Kaplan; Gordon W Moran; Paul L Beck; Remo Panaccione
Drug-induced inflammatory bowel disease and IBD-like conditions.
Inflammatory bowel diseases 2013;19(2):445-56.
2013: C H Seow; Remo Panaccione
Commentary: detection of infliximab levels and anti-infliximab antibodies.
Alimentary pharmacology & therapeutics 2013;37(1):153-4.
2012: Gilaad G Kaplan; Anthony MacLean; Natalie Molodecky; Gordon W Moran; Donald Buie; Subrata Ghosh; James Hubbard; Marie-Claude Proulx; Ali Rezaie; Cynthia H Seow; Remo Panaccione
Decreasing colectomy rates for ulcerative colitis: a population-based time trend study.
The American journal of gastroenterology 2012;107(12):1879-87.
2012: Emma Allen-Vercoe; Michelle Daigneault; Sylvia H Duncan; Harry J Flint; Lindsey O'Neal; Remo Panaccione; Aaron White; Paul A Lawson
Anaerostipes hadrus comb. nov., a dominant species within the human colonic microbiota; reclassification of Eubacterium hadrum Moore et al. 1976.
Anaerobe 2012;18(5):523-9.
2012: William J Sandborn; Bruce E Sands; Stefan Schreiber; Stephan R Targan; Richard Aranda; Brian Bressler; Jean-Frederic Colombel; Karl Geboes; Sheila Gujrathi; Allison Luo; Remo Panaccione; Yun Peng; Paul Rutgeerts; Luisa Salter-Cid; Stephen B Hanauer
Abatacept for Crohn's disease and ulcerative colitis.
Gastroenterology 2012;143(1):62-69.e4.
2012: Yvette Leung; Remo Panaccione; KP Rioux; Russell D Cohen; Shane M Devlin; Stephen B Hanauer; James Hubbard; Sarah Kamhawi; Gilaad G Kaplan; Lidia Stasiak; David T Rubin
Assessment of variables associated with smoking cessation in Crohn's disease.
Digestive diseases and sciences 2012;57(4):1026-32.
2012: Remo Panaccione; Laurent Peyrin-Biroulet; Toshifumi Hibi; Stefan Schreiber
Implementing changes in clinical practice to improve the management of Crohn's disease.
Journal of Crohn's & colitis 2012;6 Suppl 2():S235-42.
2012: Alain Bitton; Donald Buie; Robert Enns; Brian G Feagan; Anne M Griffiths; Jennifer L Jones; John K Marshall; Remo Panaccione; Scott Whittaker
Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements.
The American journal of gastroenterology 2012;107(2):179-94; author reply 195.
2012: Christopher Ma; Robert P Myers; Geoffrey C Nguyen; Remo Panaccione; Marie-Claude Proulx; Martin Prusinkiewicz; Hude Quan; Marcelo Crespin; Shanika DeSilva; Subrata Ghosh; James Hubbard; Gilaad G Kaplan
Postoperative complications following colectomy for ulcerative colitis: a validation study.
BMC gastroenterology 2012;12():39.
2011: Shanika de Silva; Andrew Fong; Subrata Ghosh; James Hubbard; Belle S Kaplan; Christopher Ma; Anthony Maclean; Remo Panaccione; Marie-Claude Proulx; Martin Prusinkiewicz; Paul L Beck; Donald Buie; Marcelo Crespin; Gilaad G Kaplan
Postoperative complications and mortality following colectomy for ulcerative colitis.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2011;9(11):972-80.
2011: Jaclyn Strauss; Paul L Beck; Rebekah DeVinney; Gilaad G Kaplan; Tarah Lynch; Remo Panaccione; KP Rioux; Emma Allen-Vercoe
Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host.
Inflammatory bowel diseases 2011;17(9):1971-8.
2011: David T Rubin; Jingdong Chao; Remo Panaccione; Anne M Robinson
A practical, evidence-based guide to the use of adalimumab in Crohn's disease.
Current medical research and opinion 2011;27(9):1803-13.
2011: Remo Panaccione; Shamsul Alam; David Binion; Naijun Chen; Benoît Guerette; Edward V Loftus; Kevin McHugh; Parvez Mulani; Jingdong Chao
Efficacy and safety of adalimumab in Canadian patients with moderate to severe Crohn's disease: results of the Adalimumab in Canadian SubjeCts with ModErate to Severe Crohn's DiseaSe (ACCESS) trial.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2011;25(8):419-25.
2011: Natalie A Molodecky; Remo Panaccione; Herman W Barkema; Subrata Ghosh; Gilaad G Kaplan
Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases.
Inflammatory bowel diseases 2011;17(8):1792-9.
2011: Chadwick Williams; Subrata Ghosh; Remo Panaccione; KP Rioux
Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease.
Therapeutic advances in gastroenterology 2011;4(4):237-48.
2011: Allen W Lim; Remo Panaccione; Cynthia H Seow
Exploring the role of monitoring anti-TNFα drug and antibody levels in the management of inflammatory bowel disease.
Therapeutic advances in gastroenterology 2011;4(2):145-51.
2011: Carla S Coffin; Hughie F Fraser; Remo Panaccione; Subrata Ghosh
Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease.
Inflammatory bowel diseases 2011;17(1):479-84.
2010: Rachel Vanderploeg; Remo Panaccione; Subrata Ghosh; KP Rioux
Influences of intestinal bacteria in human inflammatory bowel disease.
Infectious disease clinics of North America 2010;24(4):977-93, ix.
2010: Gilaad G Kaplan; James Hubbard; Joshua Korzenik; Bruce Sands; Remo Panaccione; Subrata Ghosh; Amanda J Wheeler; Paul Villeneuve
The inflammatory bowel diseases and ambient air pollution: a novel association.
The American journal of gastroenterology 2010;105(11):2412-9.
2010: Karen D Papay; Vincent G Falck; Steen S Poulsen; Remo Panaccione; Jens F Rehfeld; Martin A Storr
Juvenile polyposis of the stomach--a novel cause of hypergastrinemia.
Nature reviews. Gastroenterology & hepatology 2010;7(10):583-8.
2010: Subrata Ghosh; Remo Panaccione
Anti-adhesion molecule therapy for inflammatory bowel disease.
Therapeutic advances in gastroenterology 2010;3(4):239-58.
2010: Remo Panaccione; J-F Colombel; William J Sandborn; Paul Rutgeerts; G R D'Haens; A M Robinson; J Chao; P M Mulani; P F Pollack
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease.
Alimentary pharmacology & therapeutics 2010;31(12):1296-309.
2010: Remo Panaccione; Subrata Ghosh
Optimal use of biologics in the management of Crohn's disease.
Therapeutic advances in gastroenterology 2010;3(3):179-89.
2010: Matt Shale; Markus Czub; Gilaad G Kaplan; Remo Panaccione; Subrata Ghosh
Anti-tumor necrosis factor therapy and influenza: keeping it in perspective.
Therapeutic advances in gastroenterology 2010;3(3):173-7.
2010: David T Rubin; Marla C Dubinsky; Remo Panaccione; Corey A Siegel; David Binion; Sunanda V Kane; Joseph Hopper
The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey.
Digestive diseases and sciences 2010;55(4):1044-52.
2010: Shanika de Silva; Shane M Devlin; Remo Panaccione
Optimizing the safety of biologic therapy for IBD.
Nature reviews. Gastroenterology & hepatology 2010;7(2):93-101.
2010: Shane M Devlin; Remo Panaccione
Evolving inflammatory bowel disease treatment paradigms: top-down versus step-up.
The Medical clinics of North America 2010;94(1):1-18.
2010: M J Shale; C H Seow; C S Coffin; G G Kaplan; Remo Panaccione; Subrata Ghosh
Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease.
Alimentary pharmacology & therapeutics 2010;31(1):20-34.
2009: Shane M Devlin; Remo Panaccione
Evolving inflammatory bowel disease treatment paradigms: top-down versus step-up.
Gastroenterology clinics of North America 2009;38(4):577-94.
2009: Cynthia H Seow; Shanika de Silva; Gilaad G Kaplan; Shane M Devlin; Subrata Ghosh; Remo Panaccione
Managing the risks of IBD therapy.
Current gastroenterology reports 2009;11(6):509-17.
2009: C Ma; Remo Panaccione; Steven J Heitman; Shane M Devlin; S Ghosh; Gilaad G Kaplan
Systematic review: the short-term and long-term efficacy of adalimumab following discontinuation of infliximab.
Alimentary pharmacology & therapeutics 2009;30(10):977-86.
2009: Gilaad G Kaplan; Elijah Dixon; Remo Panaccione; Andrew Fong; Li Chen; Mieczyslaw Szyszkowicz; Amanda Wheeler; Anthony MacLean; W Donald Buie; Terry Leung; Steven J Heitman; Paul Villeneuve
Effect of ambient air pollution on the incidence of appendicitis.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2009;181(9):591-7.
2009: Jean-Frédéric Colombel; William J Sandborn; Remo Panaccione; Anne M Robinson; Winnie Lau; Ju Li; Alexandra T Cardoso
Adalimumab safety in global clinical trials of patients with Crohn's disease.
Inflammatory bowel diseases 2009;15(9):1308-19.
2009: Jean-Frédéric Colombel; D A Schwartz; William J Sandborn; M A Kamm; Geert D'Haens; Paul Rutgeerts; Robert Enns; Remo Panaccione; Stefan Schreiber; J Li; J D Kent; K G Lomax; Paul F Pollack
Adalimumab for the treatment of fistulas in patients with Crohn's disease.
Gut 2009;58(7):940-8.
2009: Matthew Shale; Gilaad G Kaplan; Remo Panaccione; Subrata Ghosh
Isotretinoin and intestinal inflammation: what gastroenterologists need to know.
Gut 2009;58(6):737-41.
2009: Gilaad G Kaplan; Remo Panaccione; James N Hubbard; Geoffrey C Nguyen; Abdel Aziz M Shaheen; Christopher Ma; Shane M Devlin; Yvette Leung; Robert P Myers
Inflammatory bowel disease patients who leave hospital against medical advice: predictors and temporal trends.
Inflammatory bowel diseases 2009;15(6):845-51.
2009: David T Rubin; Corey A Siegel; Sunanda V Kane; David Binion; Remo Panaccione; Marla C Dubinsky; Edward V Loftus; Joseph Hopper
Impact of ulcerative colitis from patients' and physicians' perspectives: Results from the UC: NORMAL survey.
Inflammatory bowel diseases 2009;15(4):581-8.
2009: Idan Roifman; Yichun C Sun; Jason P Fedwick; Remo Panaccione; Andre G Buret; Hongqun Liu; Alaa Rostom; Todd J Anderson; Paul L Beck
Evidence of endothelial dysfunction in patients with inflammatory bowel disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(2):175-82.
2009: Remo Panaccione
Biological therapy in Crohn's disease: is it an issue of how hard you strike or how fast you strike?
Inflammatory bowel diseases 2009;15(2):311-2.
2009: Subrata Ghosh; Gilaad Kaplan; Remo Panaccione
Granulocyte-monocyte apheresis for the treatment of ulcerative colitis--is this the end of the road?
Nature clinical practice. Gastroenterology & hepatology 2009;6(1):6-7.
2008: Matthew Shale; Ed Kanfer; Remo Panaccione; Subrata Ghosh
Hepatosplenic T cell lymphoma in inflammatory bowel disease.
Gut 2008;57(12):1639-41.
2008: Brian G Feagan; Remo Panaccione; William J Sandborn; Geert D'Haens; Stefan Schreiber; Paul J Rutgeerts; Edward V Loftus; Kathleen G Lomax; Andrew P Yu; Eric Q Wu; Jingdong Chao; Parvez Mulani
Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study.
Gastroenterology 2008;135(5):1493-9.
2008: Jennifer Jones; Edward V Loftus; Remo Panaccione; Li-Sheng Chen; Sandra Peterson; Joseph McConnell; Linnea Baudhuin; Karen Hanson; Brian G Feagan; Scott W Harmsen; Alan R Zinsmeister; Emelie Helou; William J Sandborn
Relationships between disease activity and serum and fecal biomarkers in patients with Crohn's disease.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(11):1218-24.
2008: Remo Panaccione
Crohn's disease: we are in it for the long haul. Interview by Paul C Adams.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2008;22(10):803-4.
2008: Brian Yan; Remo Panaccione; Lloyd Sutherland
I am Jewish: what is my risk of developing Crohn's disease?
Inflammatory bowel diseases 2008;14 Suppl 2():S26-7.
2008: Gil Kaplan; Remo Panaccione
Use of combination therapy in IBD.
Inflammatory bowel diseases 2008;14 Suppl 2():S219-21.
2008: Remo Panaccione
Are physicians biased in their choices of therapy to recommend to patients with IBD?
Inflammatory bowel diseases 2008;14 Suppl 2():S204-5.
2008: Kerri Novak; Lloyd Sutherland; Remo Panaccione
Medical induction of active Crohn's ileitis: evidence-based management.
Inflammatory bowel diseases 2008;14 Suppl 2():S247-8.
2008: Saleh Alqhatani; Lloyd Sutherland; Remo Panaccione
Are antibiotics useful in the treatment of IBD?
Inflammatory bowel diseases 2008;14 Suppl 2():S249-50.
2008: Remo Panaccione; P Rutgeerts; William J Sandborn; Brian G Feagan; Stefan Schreiber; S Ghosh
Review article: treatment algorithms to maximize remission and minimize corticosteroid dependence in patients with inflammatory bowel disease.
Alimentary pharmacology & therapeutics 2008;28(6):674-88.
2008: Jennifer Jones; Remo Panaccione
Biologic therapy in Crohn's disease: state of the art.
Current opinion in gastroenterology 2008;24(4):475-81.
2008: Shane M Devlin; Remo Panaccione
Adalimumab for the treatment of Crohn's disease.
Expert opinion on biological therapy 2008;8(7):1011-9.
2008: Yvette Leung; Remo Panaccione; Brenda Hemmelgarn; Jennifer Jones
Exposing the weaknesses: a systematic review of azathioprine efficacy in ulcerative colitis.
Digestive diseases and sciences 2008;53(6):1455-61.
2008: Remo Panaccione; Richard N Fedorak; Guy Aumais; Edmond-Jean Bernard; C N Bernstein; Alain Bitton; Ken Croitoru; Levinus A Dieleman; Robert Enns; Brian G Feagan; D Franchimont; Gordon R Greenberg; Anne M Griffiths; John K Marshall; P Pare; S Patel; R Penner; C Render; Ernest Seidman; A Hillary Steinhart
Review and clinical perspectives for the use of infliximab in ulcerative colitis.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2008;22(3):261-72.
2008: Shani Desilva; Gil Kaplan; Remo Panaccione
Sequential therapies for Crohn's disease: optimizing conventional and biologic strategies.
Reviews in gastroenterological disorders 2008;8(2):109-16.
2008: Yvette Leung; Remo Panaccione
Anti-adhesion molecule strategies for Crohn disease.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2008;22(4):259-64.
2008: Jennifer J Williams; Gilaad G Kaplan; Sapna Makhija; Stefan J Urbanski; Marc Dupre; Remo Panaccione; Paul L Beck
Microscopic colitis-defining incidence rates and risk factors: a population-based study.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2008;6(1):35-40.
2007: Sapna Makhija; M Trotter; E Wagner; Sylvain Coderre; Remo Panaccione
Refractory Crohn's disease of the vulva treated with infliximab: a case report.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2007;21(12):835-7.
2007: Gilaad G Kaplan; Steven J Heitman; Robert J Hilsden; Stefan J Urbanski; Robert P Myers; Samuel S Lee; Kelly W Burak; Mark Swain; Remo Panaccione
Population-based analysis of practices and costs of surveillance for colonic dysplasia in patients with primary sclerosing cholangitis and colitis.
Inflammatory bowel diseases 2007;13(11):1401-7.
2007: William J Sandborn; Stephen B Hanauer; Paul Rutgeerts; R N Fedorak; M Lukas; D G MacIntosh; Remo Panaccione; D Wolf; J D Kent; B Bittle; J Li; Paul F Pollack
Adalimumab for maintenance treatment of Crohn's disease: results of the CLASSIC II trial.
Gut 2007;56(9):1232-9.
2007: William J Sandborn; Paul Rutgeerts; Robert Enns; Stephen B Hanauer; Jean-Frédéric Colombel; Remo Panaccione; Geert D'Haens; Ju Li; Marie R Rosenfeld; Jeffrey D Kent; Paul F Pollack
Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial.
Annals of internal medicine 2007;146(12):829-38.
2007: Stephan R Targan; Brian G Feagan; Richard N Fedorak; Bret A Lashner; Remo Panaccione; Daniel H Present; Martina E Spehlmann; Paul J Rutgeerts; Zsolt Tulassay; Miroslava Volfova; Douglas C Wolf; Chito Hernandez; Jeffrey Bornstein; William J Sandborn
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.
Gastroenterology 2007;132(5):1672-83.
2007: Jean-Frédéric Colombel; William J Sandborn; Paul Rutgeerts; Robert Enns; Stephen B Hanauer; Remo Panaccione; Stefan Schreiber; Dan Byczkowski; Ju Li; Jeffrey D Kent; Paul F Pollack
Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial.
Gastroenterology 2007;132(1):52-65.
2006: Yvette Leung; Michelle Geddes; Jan Storek; Remo Panaccione; Paul L Beck
Hematopoietic cell transplantation for Crohn's disease; is it time?
World journal of gastroenterology : WJG 2006;12(41):6665-73.
2006: Remo Panaccione
The approach to dysplasia surveillance in inflammatory bowel disease.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2006;20(4):251-3.
2006: Stephen B Hanauer; William J Sandborn; Paul Rutgeerts; Richard N Fedorak; Milan Lukas; Donald MacIntosh; Remo Panaccione; Douglas Wolf; Paul F Pollack
Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial.
Gastroenterology 2006;130(2):323-33; quiz 591.
2006: Shaun A C Medlicott; Sylvain Coderre; Garnet Horne; Remo Panaccione
Multimodal immunosuppressant therapy in steroid-refractory common variable immunodeficiency sprue: a case report complicating cytomegalovirus infection.
International journal of surgical pathology 2006;14(1):101-6.
2005: Gilaad G Kaplan; Duane Bates; Dawn McDonald; Remo Panaccione; Joseph Romagnuolo
Inappropriate use of intravenous pantoprazole: extent of the problem and successful solutions.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2005;3(12):1207-14.
2005: Remo Panaccione; Jose Geraldo P Ferraz; Paul Beck
Advances in medical therapy of inflammatory bowel disease.
Current opinion in pharmacology 2005;5(6):566-72.
2005: William J Sandborn; Jean-Frédéric Colombel; Roberts Enns; Brian G Feagan; Stephen B Hanauer; Ian Craig Lawrance; Remo Panaccione; Martin Sanders; Stefan Schreiber; Stephan R Targan; Sander J H van Deventer; Ronald Goldblum; Darrin Despain; Gary S Hogge; Paul Rutgeerts
Natalizumab induction and maintenance therapy for Crohn's disease.
The New England journal of medicine 2005;353(18):1912-25.
2005: Remo Panaccione
Methotrexate" "lessons from rheumatology".
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2005;19(9):541-2.
2004: S Ian Gan; Stefan J Urbanski; Sylvain Coderre; Remo Panaccione
Isolated visceral small artery fibromuscular hyperplasia-induced ischemic colitis mimicking inflammatory bowel disease.
The American journal of gastroenterology 2004;99(10):2058-62.
2004: Remo Panaccione; Richard N Fedorak; Guy Aumais; Charles N Bernstein; Alain Bitton; Ken Croitoru; Robert Enns; Brian G Feagan; Marty Fishman; Gordon Greenberg; Anne Griffiths; John K Marshall; Imran Rasul; Daniel C Sadowski; Ernest Seidman; Hillary Steinhart; Lloyd Sutherland; Eric Walli; Gary Wild; C Noel Williams; Mary Zachos
Canadian Association of Gastroenterology Clinical Practice Guidelines: the use of infliximab in Crohn's disease.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2004;18(8):503-8.
2004: Remo Panaccione; William J Sandborn
Medical therapy of Crohn disease.
Current opinion in gastroenterology 2004;20(4):351-9.
2004: Remo Panaccione
The ultimate therapeutic goal: establishing and maintaining quality of life.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2004;18(7):465-6.
2004: Elena Ricart; Remo Panaccione; Edward V Loftus; William J Tremaine; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
Autoimmune disorders and extraintestinal manifestations in first-degree familial and sporadic inflammatory bowel disease: a case-control study.
Inflammatory bowel diseases 2004;10(3):207-14.
2004: Gil Kaplan; Remo Panaccione
The race to block TNF-alpha: the caution flag is raised again.
Inflammatory bowel diseases 2004;10(1):61-2.
2003: Dawnelle R Topstad; Remo Panaccione; John A Heine; Douglas R E Johnson; Anthony R MacLean; W Donald Buie
Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: a single center experience.
Diseases of the colon and rectum 2003;46(5):577-83.
2002: David A Schwartz; Edward V Loftus; William J Tremaine; Remo Panaccione; W Scott Harmsen; Alan R Zinsmeister; William J Sandborn
The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota.
Gastroenterology 2002;122(4):875-80.
2001: CL Nash; Remo Panaccione; Lloyd R Sutherland; Jonathan B Meddings
Giant cell myocarditis, in a patient with Crohn's disease, treated with etanercept--a tumour necrosis factor-alpha antagonist.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2001;15(9):607-11.
2001: Remo Panaccione
Infliximab for the treatment of Crohn's disease: review and indications for clinical use in Canada.
Canadian journal of gastroenterology = Journal canadien de gastroenterologie 2001;15(6):371-5.
2001: Elena Ricart; Remo Panaccione; Edward V Loftus; William J Tremaine; William J Sandborn
Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.
The American journal of gastroenterology 2001;96(3):722-9.
2001: Brian G Feagan; R Enns; Richard N Fedorak; Remo Panaccione; P Paré; A Hillary Steinhart; Gary Wild
Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics.
The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 2001;8(4):188-98.
1999: Remo Panaccione; James C Gregor; Richard P E Reynolds; Harold G Preiksaitis
Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: a cost minimization analysis.
Gastrointestinal endoscopy 1999;50(4):492-8.
1999: Elena Ricart; Remo Panaccione; Edward V Loftus; William J Tremaine; William J Sandborn
Successful management of Crohn's disease of the ileoanal pouch with infliximab.
Gastroenterology 1999;117(2):429-32.